Patent · US Expired

13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension

US6232344A · kind A · utility

38Cited by
4References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 1999
Grant dateMay 15, 2001
Priority date—
Expiry dateMay 21, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C405/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

13-Oxa analogs of certain prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.